UMCU

Kuros Reports First Patient Treated in Randomized Controlled Trial of MagnetOs in Spinal Fusion

SCHLIEREN (ZURICH), Switzerland, Sept. 27, 2018 (GLOBE NEWSWIRE) — Kuros Biosciences (SIX: KURN) today announced that the first patient has…